132392-65-5Relevant articles and documents
Method of treating type I diabetes
-
, (2008/06/13)
Provided is a method for treating Type I diabetes in mammals utilizing certain aryl-substituted rhodanine derivatives.
Version: 1.0
Creation Date: Aug 15, 2017
Revision Date: Aug 15, 2017
Product name | 5-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-3-(methylamino)-1,3-thiazolidin-4-one |
---|
Product number | - |
---|---|
Other names | 5-((3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)-3-(methylamino)-4-thiazolidinone |
Identified uses | For industry use only. |
---|---|
Uses advised against | no data available |
Emergency phone number | - |
---|---|
Service hours | Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours). |
More Details:132392-65-5 SDS
Provided is a method for treating Type I diabetes in mammals utilizing certain aryl-substituted rhodanine derivatives.